Skip to main content
Clinical Trials/NCT00791024
NCT00791024
Completed
Phase 1

Phase One Study and Two of a New Method for Local Analgesia

Ove Andersen1 site in 1 country126 target enrollmentNovember 2008

Overview

Phase
Phase 1
Intervention
CRC-Pharma 001
Conditions
Analgesia
Sponsor
Ove Andersen
Enrollment
126
Locations
1
Primary Endpoint
VAS score
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

Aim: To examine a new method to perform local anesthesia in order to diminish the inconvenience by the procedure in patients before performing intubation or oesophagogastroduodenoscopy.

Detailed Description

A phase one and two study. part one is performed as a single arm unblinded uncontrolled study in 16 obese patients undergoing awake intubation (investigational pill). The second part is a phase two study randomized single blinded study in 100 patient attending a day case endoscopy unit for oesophagogastroduodenoscopy (investigational pill versus lidocaine suspension).

Registry
clinicaltrials.gov
Start Date
November 2008
End Date
January 2010
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Ove Andersen
Responsible Party
Sponsor Investigator
Principal Investigator

Ove Andersen

Research director

Hvidovre University Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients admitted for adipositas surgery
  • Patients who attend for oesophagogastroduodenoscopy.

Exclusion Criteria

  • Severe psychiatric diseases
  • Alcohol abuse

Arms & Interventions

single arm

Intervention: CRC-Pharma 001

single arm

Intervention: lidocaine suspension

Outcomes

Primary Outcomes

VAS score

Time Frame: at day O and 3

Secondary Outcomes

  • Questionnaire( examiner and patient)(performed at day 0 and 3)

Study Sites (1)

Loading locations...

Similar Trials